DOI QR코드

DOI QR Code

Ahnak-knockout mice show susceptibility to Bartonella henselae infection because of CD4+ T cell inactivation and decreased cytokine secretion

  • Choi, Eun Wha (Department of Veterinary Clinical Pathology, College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University) ;
  • Lee, Hee Woo (Institute of Research and Development, Chaon Corp.) ;
  • Lee, Jun Sik (Department of Biology, Immunology Research Lab., College of Natural Sciences, Chosun University) ;
  • Kim, Il Yong (Laboratory of Developmental Biology and Genomics, BK21 Plus Program for Advanced Veterinary Science, Research Institute for Veterinary Science, College of Veterinary Medicine, and Korea Mouse Phenotyping Center, Seoul National University) ;
  • Shin, Jae Hoon (Laboratory of Developmental Biology and Genomics, BK21 Plus Program for Advanced Veterinary Science, Research Institute for Veterinary Science, College of Veterinary Medicine, and Korea Mouse Phenotyping Center, Seoul National University) ;
  • Seong, Je Kyung (Laboratory of Developmental Biology and Genomics, BK21 Plus Program for Advanced Veterinary Science, Research Institute for Veterinary Science, College of Veterinary Medicine, and Korea Mouse Phenotyping Center, Seoul National University)
  • Received : 2018.12.20
  • Accepted : 2019.03.20
  • Published : 2019.04.30

Abstract

The present study evaluated the role of AHNAK in Bartonella henselae infection. Mice were intraperitoneally inoculated with $2{\times}10^8$ colony-forming units of B. henselae Houston-1 on day 0 and subsequently on day 10. Blood and tissue samples of the mice were collected 8 days after the final B. henselae injection. B. henselae infection in the liver of Ahnak-knockout and wild-type mice was confirmed by performing polymerase chain reaction, with Bartonella adhesion A as a marker. The proportion of B. henselae-infected cells increased in the liver of the Ahnak-knockout mice. Granulomatous lesions, inflammatory cytokine levels, and liver enzyme levels were also higher in the liver of the Ahnak-knockout mice than in the liver of the wild-type mice, indicating that Ahnak deletion accelerated B. henselae infection. The proportion of CD4+interferon-${\gamma}$ ($IFN-{\gamma}^+$) and $CD4^+$ interleukin $(IL)-4^+$ cells was significantly lower in the B. henselae-infected Ahnak-knockout mice than in the B. henselae-infected wild-type mice. In vitro stimulation with B. henselae significantly increased $IFN-{\gamma}$ and IL-4 secretion in the splenocytes obtained from the B. henselae-infected wild-type mice, but did not increase $IFN-{\gamma}$ and IL-4 secretion in the splenocytes obtained from the B. henselae-infected Ahnak-KO mice. In contrast, $IL-1{\alpha}$, $IL-1{\beta}$, IL-6, IL-10, RANTES, and tumor necrosis $factor-{\alpha}$ secretion was significantly elevated in the splenocytes obtained from both B. henselae-infected wild-type and Ahnak-knockout mice. These results indicate that Ahnak deletion promotes B. henselae infection. Impaired $IFN-{\gamma}$ and IL-4 secretion in the Ahnak-knockout mice suggests the impairment of Th1 and Th2 immunity in these mice.

Keywords

References

  1. Guptill L, Slater L, Wu CC et al (1999) Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Vet Immunol Immunopathol 71, 233-243 https://doi.org/10.1016/S0165-2427(99)00104-X
  2. Kabeya H, Sase M, Yamashita M and Maruyama S (2006) Predominant T helper 2 immune responses against Bartonella henselae in naturally infected cats. Microbiol Immunol 50, 171-178 https://doi.org/10.1111/j.1348-0421.2006.tb03783.x
  3. Kabeya H, Yamasaki A, Ikariya M, Negishi R, Chomel BB and Maruyama S (2007) Characterization of Th1 activation by Bartonella henselae stimulation in BALB/c mice: Inhibitory activities of interleukin-10 for the production of interferon-gamma in spleen cells. Vet Microbiol 119, 290-296 https://doi.org/10.1016/j.vetmic.2006.08.010
  4. Regnath T, Mielke ME, Arvand M and Hahn H (1998) Murine Model of Bartonella henselae Infection in the Immunocompetent Host. Infect Immun 66, 5534-5536 https://doi.org/10.1128/IAI.66.11.5534-5536.1998
  5. McGuirk P and Mills KH (2002) Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 23, 450-455 https://doi.org/10.1016/S1471-4906(02)02288-3
  6. Musso T, Badolato R, Ravarino D et al (2001) Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response. Infect Immun 69, 5974-5980 https://doi.org/10.1128/IAI.69.10.5974-5980.2001
  7. Chomel BB, Abbott RC, Kasten RW et al (1995) Bartonella henselae prevalence in domestic cats in Califoria: risk factors and association between bacteremia and antibody titers. J Clin Microbiol 33, 2445-2450 https://doi.org/10.1128/JCM.33.9.2445-2450.1995
  8. Kabeya H, Umehara T, Okanishi H et al (2009) Experimental infection of cats with Bartonella henselae resulted in rapid clearance associated with T helper 1 immune responses. Microbes Infect 11, 716-720 https://doi.org/10.1016/j.micinf.2009.03.008
  9. Gentil BJ, Delphin C, Mbele GO et al (2001) The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem 276, 23253-23261 https://doi.org/10.1074/jbc.M010655200
  10. Shin JH, Kim IY, Kim YN et al (2015) Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure. PLoS One 10, e0139720 https://doi.org/10.1371/journal.pone.0139720
  11. Shin JH, Lee SH, Kim YN et al (2016) AHNAK deficiency promotes browning and lipolysis in mice via increased responsiveness to beta-adrenergic signalling. Sci Rep 6, 23426 https://doi.org/10.1038/srep23426
  12. Woo JK, Shin JH, Lee SH et al (2018) Essential role of Ahnak in adipocyte differentiation leading to the transcriptional regulation of $Bmpr1{\alpha}$ expression. Cell Death Dis 9, 864 https://doi.org/10.1038/s41419-018-0873-6
  13. Lee IH, Sohn M, Lim HJ et al (2014) Ahnak functions as a tumor suppressor via modulation of TGFbeta/Smad signaling pathway. Oncogene 33, 4675-4684 https://doi.org/10.1038/onc.2014.69
  14. Park JW, Kim IY, Choi JW et al (2018) AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res 16, 1287-1298 https://doi.org/10.1158/1541-7786.MCR-17-0726
  15. Matza D, Badou A, Kobayashi KS et al (2008) A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity 28, 64-74 https://doi.org/10.1016/j.immuni.2007.11.020
  16. Szczesny P, Linke D, Ursinus A et al (2008) Structure of the head of the Bartonella adhesin BadA. PLoS Pathog 4, e1000119 https://doi.org/10.1371/journal.ppat.1000119
  17. Arvand M, Ignatius R, Regnath T, Hahn H and Mielke ME (2001) Bartonella henselae-specific cell-mediated immune responses display a predominantly Th1 phenotype in experimentally infected C57BL/6 mice. Infect Immun 69, 6427-6433 https://doi.org/10.1128/IAI.69.10.6427-6433.2001
  18. Biedermann T, Rocken M and Carballido JM (2004) TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Investig Dermatol Symp Proc 9, 5-14 https://doi.org/10.1111/j.1087-0024.2004.00829.x
  19. Cantrell D (1996) T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14, 259-274 https://doi.org/10.1146/annurev.immunol.14.1.259
  20. Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19, 497-521 https://doi.org/10.1146/annurev.immunol.19.1.497
  21. Lee IH, Lim HJ, Yoon S et al (2008) Ahnak protein activates protein kinase C (PKC) through dissociation of the PKC-protein phosphatase 2A complex. J Biol Chem 283, 6312-6320 https://doi.org/10.1074/jbc.M706878200
  22. Kim IY, Jung J, Jang M et al (2010) 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem Biophys Res Commun 403, 428-434 https://doi.org/10.1016/j.bbrc.2010.11.048